ERBB2 and breast cancer: Also, advancements in molecular profiling techniques facilitated personalizedmedicine approaches in HER2-positive BC [61].Researchers are developing methods to identify specific genetic mutations andalterations in patients’ tumors, allowing for more targeted and tailored treatmentstrategies [62].